Cigna Group Reports Officer and Director Changes
Ticker: CI · Form: 8-K · Filed: Jun 20, 2024 · CIK: 1739940
| Field | Detail |
|---|---|
| Company | Cigna Group (CI) |
| Form Type | 8-K |
| Filed Date | Jun 20, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01, $400,000, $300,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: leadership-change, governance, officer-appointment, director-election
TL;DR
Cigna Group board and exec shake-up effective June 14th.
AI Summary
The Cigna Group filed an 8-K on June 20, 2024, reporting changes effective June 14, 2024. These changes include the departure of directors or certain officers, the election of new directors, the appointment of certain officers, and updates to compensatory arrangements for certain officers. Specific details regarding the individuals involved and the nature of the compensatory arrangements are not provided in this excerpt.
Why It Matters
Changes in a company's board of directors and executive officers can signal shifts in strategy, governance, or operational focus.
Risk Assessment
Risk Level: medium — Changes in key leadership roles can introduce uncertainty regarding future company direction and performance.
Key Players & Entities
- The Cigna Group (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- June 14, 2024 (date) — Effective date of reported changes
- June 20, 2024 (date) — Filing date of the 8-K
FAQ
What specific changes were made regarding directors and officers?
The filing indicates the departure of directors or certain officers, the election of directors, and the appointment of certain officers, but does not specify the individuals involved or the exact nature of these changes in this excerpt.
Were there any changes to executive compensation arrangements?
Yes, the filing states that there were changes related to 'Compensatory Arrangements of Certain Officers'.
When were these reported changes effective?
The changes reported in the 8-K were effective as of June 14, 2024.
What is the filing date of this 8-K report?
This 8-K report was filed on June 20, 2024.
What is the principal executive office address for The Cigna Group?
The principal executive offices are located at 900 Cottage Grove Road, Bloomfield, Connecticut 06002.
Filing Stats: 565 words · 2 min read · ~2 pages · Grade level 11.5 · Accepted 2024-06-20 16:15:30
Key Financial Figures
- $0.01 — ch registered Common Stock, Par Value $0.01 CI New York Stock Exchange , Inc. I
- $400,000 — e will receive an annual base salary of $400,000. Her 2024 Enterprise Incentive Plan Ann
- $300,000 — 2025 Long-Term Incentive Target will be $300,000. Ms. Kates will also be eligible to par
Filing Documents
- cigna8k.htm (8-K) — 24KB
- 0000950159-24-000218.txt ( ) — 191KB
- ci-20240614.xsd (EX-101.SCH) — 3KB
- ci-20240614_lab.xml (EX-101.LAB) — 33KB
- ci-20240614_pre.xml (EX-101.PRE) — 22KB
- cigna8k_htm.xml (XML) — 3KB
02
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On June 14, 2024, The Cigna Group (the "Company" or "our") appointed Jamie Kates as the Company's Chief Accounting Officer, serving as the Company's principal accounting officer, effective July 1, 2024. Ms. Kates, 44, has served as Vice President, Accounting, since October 2021, pursuant to which she managed the Evernorth Health Services accounting, compliance and consolidation functions. Prior to that, she served as Managing Director, Accounting, from January 2019 through October 2021, during which she managed the Evernorth Health Services accounting and compliance functions. Ms. Kates joined The Cigna Group in 2009 and has held roles of increasing responsibility during her tenure. Ms. Kates is a Certified Public Accountant. In connection with her appointment, Ms. Kates accepted an offer letter, pursuant to which she will receive an annual base salary of $400,000. Her 2024 Enterprise Incentive Plan Annual Target will be 50% of her annual base salary (prorated for time in role) and her 2025 Long-Term Incentive Target will be $300,000. Ms. Kates will also be eligible to participate in the Company's employee benefit plans, in accordance with their terms. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. THE CIGNA GROUP Date: June 20, 2024 By: /s/ Brian C. Evanko Brian C. Evanko Executive Vice President, Chief Financial Officer, The Cigna Group, and President and Chief Executive Officer, Cigna Healthcare